Cabergoline and oedema peripheral 
Cabergoline and oedema peripheral Patient Reports February 12, 2012
Cabergoline Side Effects Report #5080689-7
Cabergoline side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 28, 2006. Male patient, 68 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: abdominal distension, oedema peripheral, weight increased. Cabergoline dosage: 2 MG (2 MG, 1 IN 1 D), ORAL. During the same period patient was treated with TEMAZEPAM. Patient recovered.
Cabergoline Side Effects Report #4680717-4
Cabergoline side effect was reported by a Health Professional from on May 20, 2005. Female patient, 85 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: myocardial infarction, oedema peripheral. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5127987-6
Cabergoline side effect was reported by a Physician from JAPAN on Sept 27, 2006. Male patient, 82 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve disease, aortic valve incompetence, blood pressure diastolic decreased, cardiac murmur, cardiomegaly, mitral valve disease, mitral valve incompetence, oedema peripheral, pulmonary congestion. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4690050-2
Cabergoline side effect was reported by a Health Professional from on May 31, 2005. Female patient, 80 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood bicarbonate increased, blood ph decreased, cardiac failure congestive, cardiomegaly, fluid imbalance, myocardial infarction, myocardial ischaemia, oedema peripheral, pco2 increased. Cabergoline dosage: 1 MG (1 MG, QD), ORAL. During the same period patient was treated with MADOPAR, SYMMETREL, MICARDIS, SELBEX, AMLODIPINE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4594907-2
Cabergoline side effect was reported by a Physician from on Feb 10, 2005. Male patient, 76 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: ascites, congestive cardiomyopathy, fall , oedema peripheral, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with BROMOCRIPTINE MESYLATE, NULYTELY, FUROSEMIDE, ASPIRIN, SPIRONOLACTONE, MADOPAR, SOTALOL, LEKOVIT CA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5085990-9
Cabergoline side effect was reported by a Physician from JAPAN on Aug 02, 2006. Female patient, 74 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated, disseminated intravascular coagulation, dyspnoea, mitral valve incompetence, oedema peripheral, pulmonary hypertension , pulmonary oedema, tricuspid valve incompetence. Cabergoline dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient died.Cabergoline Side Effects Report #5056266-0
Cabergoline side effect was reported by a Physician from JAPAN on July 05, 2006. Male patient, 73 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, oedema peripheral. Cabergoline dosage: 2 MG (2 MG, 1 IN 1 D), ORAL. During the same period patient was treated with MENESIT. Patient was hospitalized. Patient died on 01/01/2006.Cabergoline Side Effects Report #5078458-7
Cabergoline side effect was reported by a Physician from JAPAN on July 26, 2006. Male patient, 73 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dementia , lung neoplasm malignant, oedema peripheral, respiratory failure. Cabergoline dosage: 1 MG (1 MG, 1 IN 1 D), ORAL. During the same period patient was treated with MENESIT. Patient was hospitalized. Patient died on 02/10/2004.Cabergoline Side Effects Report #5131828-0
Cabergoline side effect was reported by a Physician from DENMARK on Oct 02, 2006. Male patient, 72 years of age, weighting 174.2 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute myocardial infarction, ascites, atrioventricular block third degree, coronary artery disease , coronary artery occlusion, dilatation atrial, ejection fraction decreased, oedema peripheral, pericardial effusion. Cabergoline dosage: 4 MG (4 MG, 1 IN 1 D); ORAL. During the same period patient was treated with ASPIRIN, SELEGILINE, IMDUR, FUROSEMIDE, ODRIK, SPIRIX, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5414313-8
Cabergoline side effect was reported by a Physician from JAPAN on Aug 02, 2007. Female patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, dyspnoea, oedema peripheral, palpitations. Cabergoline dosage: unknown. During the same period patient was treated with DOPASTON, TOLEDOMIN, THYRADIN S. Patient recovered.Cabergoline Side Effects Report #4617892-3
Cabergoline side effect was reported by a Physician from on Mar 09, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: akinesia, cardiac failure, dyskinesia, dyspnoea exertional, oedema peripheral, pleural effusion, weight increased. Cabergoline dosage: 2 MG, ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4658886-1
Cabergoline side effect was reported by a Physician from on Apr 26, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood pressure systolic increased, cardiac failure, mitral valve prolapse, oedema peripheral, pleural effusion, pulmonary valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 2 MG, ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5618759-4
Cabergoline side effect was reported by a Physician from SWEDEN on Feb 06, 2008. Male patient, 69 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute myocardial infarction, anaemia, atrioventricular block, atrioventricular block complete, back pain , inflammation, movement disorder , oedema peripheral, pain in extremity. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR QUICK. Patient was hospitalized. Patient died on 12/01/2006.Cabergoline Side Effects Report #4680707-1
Cabergoline side effect was reported by a Physician from on May 19, 2005. Male patient, 67 years of age, weighting 132.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood triglycerides increased, muscle swelling, oedema peripheral. Cabergoline dosage: unknown. During the same period patient was treated with SIFROL, LEVODOPA, PERMAX, EPADEL, DEPAS. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4692177-8
Cabergoline side effect was reported by a Physician from on June 01, 2005. Male patient, 67 years of age, weighting 132.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood triglycerides increased, hypothyroidism, muscle swelling, muscular dystrophy , oedema peripheral. Cabergoline dosage: unknown. During the same period patient was treated with SIFROL, CARBIDOPA, PERMAX, EPADEL, DEPAS. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5097066-5
Cabergoline side effect was reported by a Physician from AUSTRALIA on Aug 23, 2006. Female patient, 54 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: oedema peripheral, red blood cell sedimentation rate increased, retroperitoneal fibrosis. Cabergoline dosage: 4 MG (4 MG, 1 D), ORAL. Patient recovered.Cabergoline Side Effects Report #5118741-X
Cabergoline side effect was reported by a Physician from AUSTRALIA on Sept 14, 2006. Female patient, 54 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: oedema peripheral, red blood cell sedimentation rate increased, retroperitoneal fibrosis. Cabergoline dosage: 4 MG (4MG, 1 IN 1 D), ORAL. Patient recovered.Cabergoline Side Effects Report #5087061-4
Cabergoline side effect was reported by a Physician from GERMANY on Aug 08, 2006. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: antinuclear antibody increased, aortic valve sclerosis, mitral valve sclerosis, oedema peripheral, tricuspid valve sclerosis. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5106231-X
Cabergoline side effect was reported by a Physician from GERMANY on Aug 30, 2005. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: antinuclear antibody increased, aortic valve sclerosis, incorrect dose administered, mitral valve sclerosis, oedema peripheral, tricuspid valve sclerosis. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5133242-0
Cabergoline side effect was reported by a Physician from GERMANY on Oct 05, 2006. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: antinuclear antibody increased, aortic valve incompetence, aortic valve sclerosis, dilatation ventricular, mitral valve incompetence, mitral valve prolapse, mitral valve sclerosis, oedema peripheral, treatment noncompliance. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5065267-8
Cabergoline side effect was reported by a Physician from TURKEY on July 13, 2006. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: gait disturbance, oedema peripheral, pain
, skin discolouration, venous occlusion. Cabergoline dosage: 6 MG, ORAL. During the same period patient was treated with ESCITALOPRAM, LEVOTHYROXINE. Patient recovered.